glp-1 and naion Agonists Risk: Swedish Study | David Berger posted on the topic MHRA-publishes-updated-GLP-1-guidance-due-to-NAION-risk

The most common side effects reported in clinical trials are gastrointestinal issues such as nausea, vomiting, and diarrhea

This method is suitable for people who are anxious about needle injections

The decades-old stepwise approach to type 2 diabetes treatment can delay the use of effective modern therapies, allowing high blood sugar and related complications to progress

Joint discomfort, gut issues, and slow recovery from exercise are common barriers that can stall progress

Appl Microbiol Biotechnol 64 : 625-635

Therefore, GLP-1RAs can provide protective effects on the above undesirable physiological phenomena in cardiomyocytes